We have fantastic speakers and thought leaders lined up for this year’s meeting. And just like past Annual Meetings, we will have several named lectures – given by speakers who embody the high standards and achievements of the physicians for whom the lectures are named. At the 2018 Annual Meeting, Nov. 15-19 in Seattle, we are excited to present these can’t-miss lectures given by the best of the best. They include the:
- John P. McGovern Lecture, Lessons Learned from the Pediatric Studies in the NIH Asthma Network, Saturday, Nov. 17, 8:30 – 9:00 am, presented by Stanley Szefler, MD, FACAAI. Hear all about key National Institutes of Health asthma network studies that have led to important insights for the management of childhood asthma. These studies serve as a model for future research related to personalized medicine, preventing asthma exacerbations and altering the natural history of asthma.
- Daniel J. Goodman Lecture, The Role of Shared Decision-making in Managing Food Allergy in the Office-based Setting, Sunday, Nov. 18, 8:05 – 8:30 am, presented by Matthew Greenhawt, MD, MSc, MBA, FACAAI. Food allergy therapies are on the horizon and shared decision-making regarding helping a patient choose the best option will become a key component of everyday clinical practice. Attendees will gain an overview of the principles of shared decision-making, learn an approach to this with respect to food allergy treatments, and learn how to anticipate and overcome challenges involved with shared decision-making to enhance future patient encounters for the better.
- Bela Schick Lecture, Academic and Community Allergists/Immunologists: A Critical Partnership, Sunday, Nov. 18, 9:00 – 9:30 am, presented by Gailen Marshall, Jr., MD, PhD, FACAAI. The future of allergy/immunology (AI) in our country is dependent upon the supply of new, well-trained clinicians. They come from ACGME-accredited training programs which are staffed by academic allergist/immunologists, often with participation from community AI specialists. Yet AI divisions are under significant challenges in U.S. medical schools due to limited extramural research funds, competition for intramural educational dollars (for both faculty and fellows) and competition between academic and community AI specialists for well-insured patients. These facts can be viewed as bad news for both types of allergist/immunologists. However, this is a golden opportunity to foster partnerships between academia and the community with defined components for improved practice opportunities, educational efforts and clinical research programs that can keep our field viable and vibrant for decades to come.
- Bernard Berman Memorial Lecture, Anaphylaxis – Management and Prevention, Monday, Nov 19, 8:05 – 8:30 am, presented by Anne Ellis, MD, MSc, FACAAI. Anaphylaxis is one disease state allergists are uniquely equipped to evaluate, manage, diagnose and educate our patients about. They see it, they cause it, they treat it, they prevent it…they own it. All practicing allergists should have top-notch, up to date information about optimal care of patients who have experienced anaphylaxis or are at risk for anaphylaxis.
Join us in Seattle – register now for the Annual Meeting. If you like to plan ahead, make sure you save space in your schedule for our top presenters!